Nippon India Pharma Fund - IDCW Option
(Erstwhile Reliance Pharma Fund-Dividend Plan)
Fund House: Nippon India Mutual Fund| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 05-06-2004 |
| Asset Class: Equity |
| Benchmark: BSE Healthcare TRI |
| TER: 1.81% As on (31-10-2024) |
| Status: Open Ended Schemes |
| Minimum Investment: 5000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 8,688.65 Cr As on 31-10-2024(Source:AMFI) |
| Turn over: 12% | Exit Load: levied on the Units redeemed will be the rate prevailing at the time of the allotment of the Units. For Special products registrations, load for each transaction is based on the load structure applicable as on the registration date. |
127.096
1.16 (0.9146%)
20.29%
Benchmark: 15.28%
PERFORMANCE
Returns Type:
of :
Start :
End :
Period:
This Scheme
-
vs
NIFTY Healthcare TRI
-
Gold
-
PPF
-
Returns Type:
of :
Period:
Start :
Period:
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
Time Taken To Multiply
2x
4x
5x
10x
FUND
1 Years 11 Months
6 Years 1 Months
9 Years 6 Months
19 Years 5 Months
FD
11 years 10 Months
GOLD
8 years 9 Months
NIFTY
5 years 5 Months
Investment Objective
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
Current Asset Allocation (%)
Indicators
| Standard Deviation | 14.36 |
| Sharpe Ratio | 0.61 |
| Alpha | 1.08 |
| Beta | 0.93 |
| Yield to Maturity | - |
| Average Maturity | - |
PEER COMPARISON
Scheme Characteristics
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Riskometer
PORTFOLIO
Market Cap Distribution
Small Cap
22.52%
Others
4.4%
Large Cap
45.96%
Mid Cap
27.12%
